Three insurtechs focused on pandemic-related solutions and products have joined Lloyd’s incubator program for promising digital start-ups.

The addition of Metabiota, Praedicat and Dialogue to Lloyd’s Lab is part of the market’s long-term response to the pandemic fallout, as it moves to expand the scope, process and timings of applicants to the program.

“The purpose of this is to help Lloyd’s and the start-ups bring to market more quickly their COVID-19 related products and innovations,” the market says in a statement.

“Lloyd’s wants to understand, model and create products that better protect customers against pandemics, and other systemic risks.”

Metabiota focuses on quantifying and mitigating epidemic and pandemic risk, Praedicat uses litigation data and science to predict the next big liability catastrophe, and Dialogue specialises in credit and political risk.